INTEGER HOLDINGS CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.6 USD | +0.66% |
|
+1.41% | +23.77% |
| May. 15 | Truist Securities Initiates Integer Holdings With Buy Rating, $137 Price Target | MT |
| May. 14 | Integer Holdings Insider Sold Shares Worth $991,739, According to a Recent SEC Filing | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.71 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +23.77% | 4.11B | C | ||
| +10.03% | 223B | B | ||
| +13.59% | 195B | B- | ||
| +20.01% | 144B | B- | ||
| +30.83% | 111B | A- | ||
| +2.28% | 65.01B | A- | ||
| +15.38% | 53.02B | B+ | ||
| +3.64% | 50.45B | B+ | ||
| +8.37% | 44.15B | A | ||
| +3.27% | 36.45B | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ITGR Stock
- Ratings Integer Holdings Corporation
